Companies » Company Overview » Ranbaxy Laboratories Ltd.
 
 
  • BSE: 500359
  • NSE: RANBAXY
  • ISIN Code: INE015A01028
  • Sector: Health care
bse
15:53 PM,30th Jan 2015
703.65
-4.35 (-0.61%)
Open 708.00
Day High 714.00
Day Low 695.75
Previous Close 708.00
Volume 87503
52-Week high 724.95
52-Week low 308.00
P/E -
Mkt Cap.(Rs cr) 29952
NSE
15:58 PM,30th Jan 2015

702.60
-6.60 (-0.93%)
Bse
15:53 PM,30th Jan 2015

703.65
-4.35 (-0.61%)
nse
15:58 PM,30th Jan 2015
702.60
-6.60 (-0.93%)
Open 709.20
Day High 714.45
Day Low 694.80
Previous Close 709.20
Volume 827773
52-Week high 725.00
52-Week low 307.50
P/E -
Mkt Cap.(Rs cr) 29952

Ranbaxy Laboratories Ltd. (RANBAXY) - Company Information

Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The company has a global footprint in 46 countries, world-class manufacturing facilities in 8 countries and serves customers in over 125 count... [More]

Key Fundamentals
Market Cap (Rs cr) 29,952
EPS - TTM (Rs)

[*C]

-
P/E Ratio (x)

[*C]

-
Face Value (Rs) 5
Latest Dividend (%) 40.00
Latest Dividend Date 28 Apr 2011
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*C]

77.51
P/B Ratio (x)

[*C]

9.08
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
695.75
714.00
Week Low/High
684.00
725.00
Month Low/High
604.00
725.00
YEAR Low/High
308.00
725.00
All TIME Low/High
4.75
725.00
Peer Group
Company Last Change(%)
Cadila Health. 1639.30 -1.45
Aurobindo Pharma 1248.10 2.08
Glenmark Pharma. 720.50 -0.04
Torrent Pharma. 1100.95 -3.24
Piramal Enterp. 833.55 -0.66
Wockhardt 1206.60 2.19
Alembic Pharma 471.10 -1.68
Returns
Period Ranbaxy Labs. Sensex NIFTY
1 Week -0.37% -0.33% -0.30%
1 Month 12.62% 6.52% 6.82%
3 Month 12.81% 6.72% 7.83%
6 Month 19.97% 11.87% 13.06%
1 Year 117.58% 42.37% 45.03%
3 Year 56.09% 73.06% 73.15%
Period Ranbaxy Labs. Sensex NIFTY
1 Week -0.57% -0.33% -0.30%
1 Month 12.52% 6.52% 6.82%
3 Month 12.72% 6.72% 7.83%
6 Month 19.89% 11.87% 13.06%
1 Year 117.42% 42.37% 45.03%
3 Year 55.91% 73.06% 73.15%
Financial Results
Particulars (Rs cr) Dec 2014 Dec 2013 %Chg
Net Sales 2618.85 2893.99 -9.51
Other Income 10.68 138.8 -92.31
Total Income 2629.53 3032.8 -13.3
Total Expenses 2521.24 2881.08 -12.49
Operating Profit 108.29 151.72 -28.63
Net Profit -1023.61 -158.49 -545.85
Equity Capital 212.24 211.55 -
SHAREHOLDING PATTERN
As on Dec 2014
Research Reports
Date Broker Action Price Report
28/01 Motilal Oswal Buy 700 PDF Icon
28/01 IDFC Outperform 700 PDF Icon
03/11 Angel Broking Neutral 634 PDF Icon
28/10 Motilal Oswal Buy 634 PDF Icon
28/10 Prabhudas Lilladhar Accumulate 634 PDF Icon
Board of directors
Director : Takashi Shoda
Chairman : Tsutomu Une
Director : Rajesh V Shah
Company Secretary : S K Patawari
Managing Director & CEO : Arun Sawhney
Director : Anthony H Wild
Director : Akihiro Watanabe
Director : Kazunori Hirokawa
Director : Percy K Shroff
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME: MNC Associate
Registered office
Plot No 90, Sector 32,
Gurgaon,Haryana-122001
Ph: 91-0124-4135000
E-mail:
URL: http://www.ranbaxy.com

Quick Links

Quick Links for Ranbaxy Laboratories

Back to Top